Literature DB >> 28152279

Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort.

Linda Mahgoub1, Tarek Kaddoura2, A Rebecca Kameny3, Paloma Lopez Ortego4, Rachel D Vanderlaan5, Ashok Kakadekar6, Frank Dicke7, Ivan Rebeyka1, Christopher A Calderone5, Andrew Redington5, Maria Jesus Del Cerro3, Jeff Fineman3, Ian Adatia1.   

Abstract

BACKGROUND: Pulmonary vein stenosis is emerging as an important clinical problem in ex-premature infants.
METHODS: We sought to describe the epidemiology of pulmonary vein stenosis affecting ex-premature infants by a multicenter retrospective cohort study of patients from seven children's hospitals diagnosed between 2000-2014.
RESULTS: We identified 39 ex-premature patients (26 males, median gestational age 28 weeks range 22-36 weeks, birth weight 1.1 kg range 433-2645-g) with pulmonary vein stenosis. Median age at diagnosis was 6.5 months (1 month-6 years). Presentation with pulmonary hypertension occurred in 26/39 (67%) and 29/39 (74%) had bronchopulmonary dysplasia, 15 (39%) were born of twin pregnancies with unaffected twin siblings. A median of 5 (range 1-25) echocardiograms was performed prior to diagnosis. The diagnosis was made using echocardiography in 22/39 (56%), by multi-detector contrast computed tomography scan (CT) in 8/39 (21%), cardiac catheterization in 6/39 (15%) patients, magnetic resonance imaging in 3/39 (8%). Freedom from death or re-stenosis was 73% at 1-year, 55% at 2, 5, and 10 years. Factors associated with shorter survival or re-stenosis were stenosis of  ≥3 pulmonary veins (P < 0.01), bilateral pulmonary vein stenosis (P < 0.01) small for gestational age (P = 0.05), aged <6 months at diagnosis (P < 0.01).
CONCLUSION: Pulmonary vein stenosis of ex-premature infants is a complex problem with poor survival, delayed diagnosis, and unsatisfactory treatment. The lack of concordance in twins suggests epigenetic or environmental factors may play a role in the development of pulmonary vein stenosis. In ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia a focused echocardiographic assessment of the pulmonary veins is required with further imaging if the echocardiogram is inconclusive.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  bronchopulmonary dysplasia; epidemiology; premature; pulmonary hypertension; pulmonary vein stenosis; survival

Mesh:

Year:  2017        PMID: 28152279     DOI: 10.1002/ppul.23679

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  26 in total

Review 1.  Primary pulmonary vein stenosis during infancy: state of the art review.

Authors:  David B Frank; Philip T Levy; Corey A Stiver; Brian A Boe; Christopher W Baird; Ryan M Callahan; Charles V Smith; Rachel D Vanderlaan; Carl H Backes
Journal:  J Perinatol       Date:  2021-03-05       Impact factor: 2.521

2.  Aerosolized deferoxamine administration in mouse model of bronchopulmonary dysplasia improve pulmonary development.

Authors:  Yanru Chen; Sha Gao; Yufei Yan; Jihong Qian; Hao Chen
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

Review 3.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

4.  The biventricular contribution to chronic pulmonary hypertension of the extremely premature infant.

Authors:  Gabriela de Carvalho Nunes; Punnanee Wutthigate; Jessica Simoneau; Adrian Dancea; Marc Beltempo; Claudia Renaud; Gabriel Altit
Journal:  J Perinatol       Date:  2022-08-25       Impact factor: 3.225

5.  Pulmonary Vein Stenosis: Outcomes in Children With Congenital Heart Disease and Prematurity.

Authors:  Michael P DiLorenzo; Ashley Santo; Jonathan J Rome; Huayan Zhang; Jennifer A Faerber; Laura Mercer-Rosa; Rachel K Hopper
Journal:  Semin Thorac Cardiovasc Surg       Date:  2018-09-29

6.  Efficacy of budesonide in the prevention and treatment of bronchopulmonary dysplasia in premature infants and its effect on pulmonary function.

Authors:  Yanli Yao; Guofei Zhang; Fei Wang; Meili Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  Diagnostic performance of CT angiography to detect pulmonary vein stenosis in children.

Authors:  Christian A Barrera; David Saul; Jordan B Rapp; Christopher L Smith; Ammie M White; David M Biko; Hansel J Otero
Journal:  Int J Cardiovasc Imaging       Date:  2019-09-09       Impact factor: 2.357

8.  Mitochondrial Fission-Mediated Lung Development in Newborn Rats With Hyperoxia-Induced Bronchopulmonary Dysplasia With Pulmonary Hypertension.

Authors:  Yuanyuan Dai; Binyuan Yu; Danyang Ai; Lin Yuan; Xinye Wang; Ran Huo; Xiaoqin Fu; Shangqin Chen; Chao Chen
Journal:  Front Pediatr       Date:  2021-01-28       Impact factor: 3.418

9.  Primary pulmonary vein stenosis among premature infants with single-vessel disease.

Authors:  Eli Zettler; Brian K Rivera; Corey Stiver; Brian Boe; Clifford Cua; Molly K Ball; Charles V Smith; Jonathan L Slaughter; Bernadette Chen; Ryan Callahan; Carl H Backes
Journal:  J Perinatol       Date:  2020-09-25       Impact factor: 2.521

10.  Prognostic Significance of Computed Tomography Findings in Pulmonary Vein Stenosis.

Authors:  Laureen Sena; Ryan Callahan; Lynn A Sleeper; Rebecca S Beroukhim
Journal:  Children (Basel)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.